top of page

< トップへ戻る

< Back to home page

検索

Limaca's Precision-GI™ Granted CMS Transitional Pass-Through (TPT) Payment

HekaBio
2024年11月8日
読了時間: 1分

Limaca Medical announced on November 7 that its Precision-GI™ Granted CMS Transitional Pass-Through (TPT) Payment

Read English press release by Limaca from here

最新記事

すべて表示

Dr. Yoshimura at the Institute of Science Tokyo has published "Efficacy and safety of diffusing alpha-emitter radiation therapy (DaRT) for head and neck cancer recurrence after radiotherapy."

Dr. Yoshimura at the Institute of Science Tokyo has published "Efficacy and safety of diffusing alpha-emitter radiation therapy (DaRT) for head and neck cancer recurrence after radiotherapy."

東京科学大学の吉村亮一教授と研究チームによる論文「放射線療法後に再発した頭頸部がんに対する拡散型アルファ線治療（DaRT）の有効性と安全性」がInternational Journal of Clinical Oncologyに掲載

東京科学大学の吉村亮一教授と研究チームによる論文「放射線療法後に再発した頭頸部がんに対する拡散型アルファ線治療（DaRT）の有効性と安全性」がInternational Journal of Clinical Oncologyに掲載

Limaca's Precision-GI™ Enters US Market

Limaca's Precision-GI™ Enters US Market

Comments

bottom of page